Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
long-acting beta2-adrenergic agonist |
| gptkbp:approvalYear |
1998
|
| gptkbp:ATCCode |
gptkb:R03AC13
|
| gptkbp:CASNumber |
43229-80-7
|
| gptkbp:chemicalClass |
gptkb:phenylethanolamine
|
| gptkbp:contraindication |
hypersensitivity to formoterol
|
| gptkbp:discoveredBy |
gptkb:AstraZeneca
|
| gptkbp:eliminationHalfLife |
10 hours
|
| gptkbp:hasMolecularFormula |
C42H56N4O14
|
| https://www.w3.org/2000/01/rdf-schema#label |
formoterol fumarate
|
| gptkbp:isomerOf |
gptkb:formoterol
|
| gptkbp:KEGGID |
D07913
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
beta2-adrenergic receptor agonist
|
| gptkbp:meltingPoint |
>200°C
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
DB00983
3083544 CHEMBL1201317 |
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
headache
tremor palpitations muscle cramps |
| gptkbp:synonym |
gptkb:Foradil
gptkb:Oxeze |
| gptkbp:UNII |
K2D2M353FA
|
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:Foradil
|
| gptkbp:bfsLayer |
5
|